Luton, Bedfordshire, United Kingdom, Sept. 05, 2022 (GLOBE NEWSWIRE) -- Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has completed and published the final copy of the detailed research report on the Adhesion Barrier Market.
The global adhesion barrier market is projected to reach USD 945.53 Million by 2029 from USD 510 Million in 2020, at a CAGR of 7.1% from 2022 to 2029.
The Seprafilm adhesion barrier is a bioresorbable membrane composed of chemically modified sodium hyaluronate (HA) and carboxymethyl cellulose (CMC). The absorbable adhesion barrier received FDA approval in 1996 and is available worldwide. To date, over two million patients have been treated with Seprafilm.
Post-surgical adhesions can cause a variety of consequences depending on the surgery, including severe abdominal pain in abdominal procedures, infertility in women after gynecological surgeries, and physical disability in patients following neurological surgeries. Because of the serious consequences of post-surgery adhesions in patients, the market for treatments like adhesion barriers is growing. In addition, as the number of procedures conducted around the world rises, the importance of these items will grow in the coming years.
Untapped emerging market is an opportunity for Adhesion Barrier Market growth.
Get Sample with Latest Trends and Future Advancements at: (Get Higher Priority for Corporate Email ID): https://exactitudeconsultancy.com/reports/7642/adhesion-barrier-market#request-a-sample
Regional Opportunities- North America is expected to hold the largest share of the global adhesion barrier market. Owning to the big firms like Johnson & Johnson, Baxter International, Integra LifeSciences, Anika Therapeutics, and FzioMed are present. In the United States, market growth is expected to be fueled by an increase in the prevalence of orthopaedic disorders along with high adoption of innovative treatment technologies. The Asia Pacific market is expected to grow at a healthy rate. The growing disease burden and amount of surgical procedures performed in emerging economies are likely to provide potential possibilities for adhesion barrier market competitors.
Market Developments
Baxter closes $350M acquisition of Sanofi’s Seprafilm adhesion barrier
UPDATE: Feb. 18, 2020: Baxter announced it completed a $350 million acquisition first announced in December of Sanofi-owned Seprafilm, a product meant to reduce adhesion barriers in patients having abdominal or pelvic laparotomy procedures. Baxter said it will immediately begin integrating Seprafilm, now part of its advanced surgery business.
Latest Press Release- https://exactitudeconsultancy.com/post/adhesion-barrier-market-growth/
Adhesion Barrier Market Scope and Segmentation
| Report Feature | Details |
| Base Year: | 2021 |
| Projection Period: | 2022-2029 |
| Market Details: | Total revenue and forecast, CAGR, Market value, share, and Y-o-Y growth by segment and region |
| Segment Covered: | by Product, by Formulation, By Application. |
| Regional and Country Scope | North America: includes the US, Canada, Mexico Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe South America: includes Brazil, Argentina and Rest of South America Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA |
| Report Coverage: | Market growth driving factors, challenges & pitfalls, opportunities, key trends, key players analysis, and region analysis |
| Market Players Covered | Sanofi S.A.,Becton Dickinson and Company, Baxter International, Inc., Johnson and Johnson, Anika Therapeutics, Inc., FzioMed, Inc, Mast Biosurgery, Inc., Innocoll Holdings PLC, and Atrium Medical Corporation. |
| Largest regional market | North America (45%) |
| market growth | Adhesion barrier penetration is quite poor in Asia Pacific, Latin America, the Middle East, and Africa. Countries like South Korea, China, India, Mexico, and Brazil, which have a large patient base for target indications like cardiovascular, orthopaedic, general/abdominal, and gynaecological disorders, are expected to offer significant growth opportunities for players in the adhesion barriers market in the coming years. In rising economies, the number of surgical operations such as heart surgeries, general and abdominal surgeries, urological surgeries, gynaecological surgeries, and orthopaedic surgeries is also on the rise. |
Browse Detailed Research Insights with TOC:
https://exactitudeconsultancy.com/reports/7642/adhesion-barrier-market/
Reluctance of surgeons to use adhesion barriers is major restrain for market growth.
Despite the concerns, surgeons are hesitant to utilise adhesion barriers due to a lack of/limited solid clinical evidence confirming the safety and efficacy of commercialised adhesion barrier solutions. Companies also have a hard time getting marketing authorization for their products due to concerns about the safety and efficacy of adhesion barriers. In addition, due to poor clinical outcomes, licenced adhesion barrier treatments have been phased out of the market in recent years.
Key Market Segments: Adhesion Barrier Market
Adhesion Barrier Market by Product, 2020-2029, (USD Million) (Thousand Units)
- Synthetic Adhesion Barrier
- Natural Adhesion Barrier
Adhesion Barrier Market by Formulation, 2020-2029, (USD Million) (Thousand Units)
- Film/Mesh
- Gel
- Liquid
Adhesion Barrier Market by Application, 2020-2029, (USD Million) (Thousand Units)
- Gynecological Surgeries
- Abdominal General Surgeries
- Orthopedic Surgeries
- Cardiovascular Surgeries
- Neurological Surgeries
- Urological Surgeries
Detailed TOC of Global Adhesion Barrier Market Research Report 2022
| 1 | Report Introduction |
| 2 | Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Adhesion Barrier Market |
| 7 | Adhesion Barrier Market Layout |
| 8 | Global Company Share Analysis – Key Companies |
| 9 | Adhesion Barrier Market Company and Product Profiles |
| 10 | Project Approach |
| 11 | Report Coverage- Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Check Discount on This Research: https://exactitudeconsultancy.com/reports/7642/adhesion-barrier-market#inquire-for-discount
Key inquiries addressed in the report:
The effects of the COVID 19 outbreak are being investigated
Our researchers give precise responses and suggest excellent market strategy avenues.
Browse More Research Topic on Healthcare Industry:
Ursodeoxycholic Acid Market
The global market for Ursodeoxycholic Acid was anticipated to grow from USD 432 million in 2020 to USD 1105 million by 2029; it is expected to grow at a CAGR of 11% during 2022 to 2029.
Ursodeoxycholic acid or ursodiol is a naturally occurring bile acid that is used dissolve cholesterol gall stones and to treat cholestatic forms of liver diseases including primary biliary cirrhosis.
https://exactitudeconsultancy.com/reports/3236/ursodeoxycholic-acid-market
Cardiovascular Information System Market
The global cardiovascular information system market is expected to grow at 8.1% CAGR from 2022 to 2029. It is expected to reach above USD 1.83 billion by 2029 from USD 0.91 billion in 2020.
Cardiovascular information system (CVIS) is a system that allows easy report generation and distribution and offers on-time access to cardiovascular electronic medical records (EMR) in images, reports, and waveforms. The CVIS refers to a digitized software solution that collects clinical information in the form of electronic medical records (EMR).
https://exactitudeconsultancy.com/reports/7492/cardiovascular-information-system-market
Irfan Tamboli (Head of Sales) - Exactitudeconsultancy Phone: + 1704 266 3234 sales@exactitudeconsultancy.com LinkedIn: https://www.linkedin.com/company/exactitudeconsultancy/
